TRIPLE THERAPY WITH OLMESARTAN, AMLODIPINE, AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH HYPERTENSION
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: HUANG, Mei Jung (Show Chwan Memorial Hospital, Pharmacy, Changhua, China Taiwan)
- Co-author(s): Mei-Jung Huang
Hypertension is an increasingly prevalent cardiovascular risk factor associated with high rates of morbidity and mortality. Patients with hypertension may require a combination of ≥2 antihypertensive agents to achieve blood pressure (BP) control.
We conducted a retrospective study data collected from July 2012 to February 2013. Totally 74 patients.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.